HuRI specifications

Information


Unique identifier OMICS_20694
Name HuRI
Alternative name Human Reference Protein Interactome Mapping Project
Restrictions to use None
Community driven No
Data access Browse
User data submission Not allowed
Maintained Yes

Maintainers


  • person_outline Frederick P. Roth <>
  • person_outline Marc Vidal <>

Publication for Human Reference Protein Interactome Mapping Project

HuRI institution(s)
Center for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Genetics, Harvard Medical School, Boston, MA, USA; Departments of Molecular Genetics and Computer Science, University of Toronto, Toronto, ON, Canada; Donnelly Centre, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, ON, Canada; Department of Biomedical Engineering, Boston University, Boston, MA, USA; Boston University School of Medicine, Boston, MA, USA; Department of Biological Sciences, Wright State University, Dayton, OH, USA; Department of Medical Protein Research, VIB, Ghent, Belgium; Cancer Research Center (Centro de Investigación del Cancer), University of Salamanca and Consejo Superior de Investigaciones Científicas, Salamanca, Spain; Joint IRB-BSC Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Center for Complex Network Research (CCNR) and Department of Physics, Northeastern University, Boston, MA, USA; Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; Department of Bioengineering, McGill University, Montreal, QC, Canada; Protein Signaling and Interactions Lab, GIGA-R, University of Liege, Liege, Belgium; Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
HuRI funding source(s)
Supported primarily by NHGRI grant R01/U01HG001715 and in part by the following grants and agencies: NHGRI P50HG004233; NHLBI U01HL098166; NHLBI U01HL108630; NCI U54CA112962; NCI R33CA132073; NIH RC4HG006066; NICHD ARRA R01HD065288, R21MH104766 and R01MH105524; NIMH R01MH091350; NSF CCF-1219007 and NSERC RGPIN-2014-03892; Canada Excellence Research Chair, Krembil Foundation, Ontario Research Fund–Research Excellence Award, Avon Foundation, Canadian Institute for Advanced Research Fellowship; grant CSI07A09 from Junta de Castilla y Leon (Valladolid, Spain), grant PI12/00624 from Ministerio de Economia y Competitividad (AES 2012, ISCiii, Madrid, Spain,) and grant iLink0398 from Consejo Superior de Investigaciones Científicas (CSIC, Madrid, Spain); Spanish Ministerio de Ciencia e Innovación (BIO2010-22073) and the European Commission through the FP7 project SyStemAge grant agreement n:306240; Group-ID Multidisciplinary Research Partnerships of Ghent University, grant FWO-V G.0864.10 from the Fund for Scientific Research-Flanders and ERC Advanced Grant N° 340941; EMBO long-term fellowship; Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative.

HuRI reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review HuRI